(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732805 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP2K6 mRNA CTD PMID:22079256 (S)-nicotine increases expression ISO RGD:620666 6480464 Nicotine results in increased expression of MAP2K6 mRNA CTD PMID:20426880 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:732805 6480464 o, p'-DDT promotes the reaction [MAP2K6 protein results in increased activity of CREBBP protein] CTD PMID:22609851 17alpha-ethynylestradiol decreases expression ISO RGD:620666 6480464 Ethinyl Estradiol results in decreased expression of MAP2K6 mRNA CTD PMID:15834898 17alpha-ethynylestradiol affects expression ISO RGD:620666 6480464 Ethinyl Estradiol affects the expression of MAP2K6 mRNA CTD PMID:26865667 17beta-estradiol multiple interactions EXP 6480464 ESR1 protein promotes the reaction [Estradiol results in decreased expression of MAP2K6 mRNA] CTD PMID:25210133 17beta-estradiol multiple interactions ISO RGD:732805 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of MAP2K6 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of MAP2K6 mRNA CTD PMID:17404688 , PMID:30165855 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of MAP2K6 mRNA CTD PMID:25210133 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP2K6 mRNA CTD PMID:14708085 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732805 6480464 Tetrachlorodibenzodioxin affects the expression of MAP2K6 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MAP2K6 mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:620666 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP2K6 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:620666 6480464 AHR protein alternative form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MAP2K6 mRNA] CTD PMID:21215274 2-nitrofluorene decreases expression ISO RGD:620666 6480464 2-nitrofluorene results in decreased expression of MAP2K6 mRNA CTD PMID:22484513 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of MAP2K6 mRNA CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases methylation EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of MAP2K6 promoter CTD PMID:26251327 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of MAP2K6 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide multiple interactions ISO RGD:732805 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K6 protein] CTD PMID:16407847 4-hydroxyphenyl retinamide increases phosphorylation ISO RGD:732805 6480464 Fenretinide results in increased phosphorylation of MAP2K6 protein CTD PMID:16407847 afimoxifene decreases response to substance ISO RGD:732805 6480464 MAP2K6 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 affects expression ISO RGD:732805 6480464 Aflatoxin B1 affects the expression of MAP2K6 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:732805 6480464 Aflatoxin B1 results in decreased expression of MAP2K6 mRNA CTD PMID:21632981 more ... aflatoxin B1 increases methylation ISO RGD:732805 6480464 Aflatoxin B1 results in increased methylation of MAP2K6 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:732805 6480464 Tretinoin results in decreased expression of MAP2K6 mRNA CTD PMID:21934132 ammonium chloride affects expression ISO RGD:620666 6480464 Ammonium Chloride affects the expression of MAP2K6 mRNA CTD PMID:16483693 amphetamine decreases expression ISO RGD:620666 6480464 Amphetamine results in decreased expression of MAP2K6 mRNA CTD PMID:30779732 andrographolide multiple interactions ISO RGD:732805 6480464 andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP2K6 protein] CTD PMID:24814888 antirheumatic drug increases expression ISO RGD:732805 6480464 Antirheumatic Agents results in increased expression of MAP2K6 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:732805 6480464 Arsenic affects the methylation of MAP2K6 gene CTD PMID:25304211 arsane decreases expression ISO RGD:732805 6480464 Arsenic results in decreased expression of MAP2K6 mRNA CTD PMID:29248574 arsenic atom affects methylation ISO RGD:732805 6480464 Arsenic affects the methylation of MAP2K6 gene CTD PMID:25304211 arsenic atom decreases expression ISO RGD:732805 6480464 Arsenic results in decreased expression of MAP2K6 mRNA CTD PMID:29248574 arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of MAP2K6 mRNA CTD PMID:18191166 arsenous acid multiple interactions EXP 6480464 MAP2K6 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16818652 arsenous acid multiple interactions ISO RGD:732805 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K6 protein CTD PMID:16818652 arsenous acid decreases expression ISO RGD:732805 6480464 Arsenic Trioxide results in decreased expression of MAP2K6 mRNA CTD PMID:26705709 arsenous acid affects response to substance EXP 6480464 MAP2K6 protein affects the susceptibility to Arsenic Trioxide CTD PMID:16818652 atrazine affects methylation ISO RGD:620666 6480464 Atrazine affects the methylation of MAP2K6 gene CTD PMID:28931070 azathioprine decreases expression ISO RGD:732805 6480464 Azathioprine results in decreased expression of MAP2K6 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of MAP2K6 mRNA CTD PMID:19770486 , PMID:21569818 benzo[a]pyrene decreases expression ISO RGD:732805 6480464 Benzo(a)pyrene results in decreased expression of MAP2K6 mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects expression ISO RGD:732805 6480464 Benzo(a)pyrene affects the expression of MAP2K6 mRNA CTD PMID:21714911 bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:732805 6480464 Mustard Gas results in increased phosphorylation of MAP2K6 protein CTD PMID:15251176 bis(2-chloroethyl) sulfide affects expression ISO RGD:620666 6480464 Mustard Gas affects the expression of MAP2K6 mRNA CTD PMID:15651846 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:732805 6480464 Diethylhexyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of MAP2K6 mRNA] CTD PMID:19850644 bisphenol A affects expression ISO RGD:620666 6480464 bisphenol A affects the expression of MAP2K6 mRNA CTD PMID:25181051 bortezomib decreases expression ISO RGD:732805 6480464 Bortezomib results in decreased expression of MAP2K6 mRNA CTD PMID:20977926 cadmium dichloride multiple interactions ISO RGD:732805 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA, Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:12634122 , PMID:18703135 cadmium dichloride increases phosphorylation ISO RGD:620666 6480464 Cadmium Chloride results in increased phosphorylation of MAP2K6 protein CTD PMID:18021293 , PMID:18703135 cadmium dichloride multiple interactions ISO RGD:620666 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 cadmium dichloride increases phosphorylation ISO RGD:732805 6480464 Cadmium Chloride results in increased phosphorylation of MAP2K6 protein CTD PMID:18703135 cannabidiol affects methylation ISO RGD:620666 6480464 Cannabidiol affects the methylation of MAP2K6 gene CTD PMID:30521419 carbamazepine affects expression ISO RGD:732805 6480464 Carbamazepine affects the expression of MAP2K6 mRNA CTD PMID:24752500 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of MAP2K6 mRNA CTD PMID:25554681 , PMID:25620056 cisplatin affects response to substance ISO RGD:732805 6480464 MAP2K6 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin multiple interactions ISO RGD:732805 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of MAP2K6 mRNA], jinfukang promotes the reaction [Cisplatin results in increased expression of MAP2K6 mRNA] CTD PMID:27392435 cisplatin increases expression ISO RGD:732805 6480464 Cisplatin results in increased expression of MAP2K6 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:620666 6480464 Cisplatin results in decreased expression of MAP2K6 mRNA CTD PMID:23558232 cisplatin multiple interactions ISO RGD:620666 6480464 trichostatin A inhibits the reaction [Cisplatin results in decreased expression of MAP2K6 mRNA] CTD PMID:23558232 cisplatin decreases response to substance ISO RGD:620666 6480464 MAP2K6 protein results in decreased susceptibility to Cisplatin CTD PMID:19578154 copper atom multiple interactions ISO RGD:732805 6480464 [NSC 689534 binds to Copper] which results in decreased expression of MAP2K6 mRNA, [Organoselenium Compounds binds to Copper] which results in decreased expression of MAP2K6 mRNA CTD PMID:20971185 , PMID:25167922 copper(0) multiple interactions ISO RGD:732805 6480464 [NSC 689534 binds to Copper] which results in decreased expression of MAP2K6 mRNA, [Organoselenium Compounds binds to Copper] which results in decreased expression of MAP2K6 mRNA CTD PMID:20971185 , PMID:25167922 copper(II) sulfate decreases expression ISO RGD:732805 6480464 Copper Sulfate results in decreased expression of MAP2K6 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:732805 6480464 Asbestos, Crocidolite results in decreased expression of MAP2K6 mRNA CTD PMID:18687144 cyclosporin A decreases expression ISO RGD:732805 6480464 Cyclosporine results in decreased expression of MAP2K6 mRNA CTD PMID:20106945 more ... cyclosporin A increases expression ISO RGD:732805 6480464 Cyclosporine results in increased expression of MAP2K6 mRNA CTD PMID:27989131 DDT multiple interactions ISO RGD:732805 6480464 MAP2K6 protein promotes the reaction [DDT results in increased activity of NOTCH1 protein] CTD PMID:18791200 deoxynivalenol multiple interactions ISO RGD:732805 6480464 AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP2K6 protein] CTD PMID:20181660 deoxynivalenol increases phosphorylation ISO RGD:732805 6480464 deoxynivalenol results in increased phosphorylation of MAP2K6 protein CTD PMID:20181660 dexamethasone decreases expression ISO RGD:620666 6480464 Dexamethasone results in decreased expression of MAP2K6 mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:620666 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MAP2K6 mRNA] CTD PMID:20032058 diarsenic trioxide decreases expression ISO RGD:732805 6480464 Arsenic Trioxide results in decreased expression of MAP2K6 mRNA CTD PMID:26705709 diarsenic trioxide multiple interactions EXP 6480464 MAP2K6 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] CTD PMID:16818652 diarsenic trioxide affects response to substance EXP 6480464 MAP2K6 protein affects the susceptibility to Arsenic Trioxide CTD PMID:16818652 diarsenic trioxide multiple interactions ISO RGD:732805 6480464 Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K6 protein CTD PMID:16818652 dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:620666 6480464 Dibutyl Phthalate results in decreased expression of MAP2K6 mRNA CTD PMID:21266533 dichloroacetic acid decreases expression EXP 6480464 Dichloroacetic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:28962523 dichromium trioxide multiple interactions ISO RGD:732805 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA CTD PMID:12634122 diclofenac affects expression ISO RGD:732805 6480464 Diclofenac affects the expression of MAP2K6 mRNA CTD PMID:24752500 dicrotophos decreases expression ISO RGD:732805 6480464 dicrotophos results in decreased expression of MAP2K6 mRNA CTD PMID:28302478 disodium selenite decreases expression ISO RGD:732805 6480464 Sodium Selenite results in decreased expression of MAP2K6 mRNA CTD PMID:16705456 disodium selenite increases expression ISO RGD:732805 6480464 Sodium Selenite results in increased expression of MAP2K6 mRNA CTD PMID:18175754 diuron decreases expression ISO RGD:620666 6480464 Diuron results in decreased expression of MAP2K6 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:732805 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects activity ISO RGD:732805 6480464 Doxorubicin affects the activity of MAP2K6 protein CTD PMID:15870702 doxorubicin affects methylation ISO RGD:620666 6480464 Doxorubicin affects the methylation of MAP2K6 gene CTD PMID:28962528 endosulfan decreases expression ISO RGD:620666 6480464 Endosulfan results in decreased expression of MAP2K6 mRNA CTD PMID:29391264 entinostat decreases expression ISO RGD:732805 6480464 entinostat results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 ethanol affects expression EXP 6480464 Ethanol affects the expression of MAP2K6 mRNA CTD PMID:30319688 filipin III multiple interactions ISO RGD:620666 6480464 Filipin inhibits the reaction [ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] more ... CTD PMID:17172471 fulvestrant multiple interactions ISO RGD:732805 6480464 MAP2K6 promotes the reaction [fulvestrant results in decreased expression of GJA1 protein] CTD PMID:29180066 gemcitabine increases phosphorylation ISO RGD:732805 6480464 gemcitabine results in increased phosphorylation of MAP2K6 protein CTD PMID:15003513 genistein decreases expression ISO RGD:732805 6480464 Genistein results in decreased expression of MAP2K6 mRNA CTD PMID:26865667 hydrogen peroxide affects expression ISO RGD:732805 6480464 Hydrogen Peroxide affects the expression of MAP2K6 mRNA CTD PMID:20044591 iron atom multiple interactions ISO RGD:620666 6480464 Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] more ... CTD PMID:17172471 iron atom increases phosphorylation ISO RGD:620666 6480464 Iron results in increased phosphorylation of MAP2K6 protein CTD PMID:17172471 iron(0) multiple interactions ISO RGD:620666 6480464 Filipin inhibits the reaction [Iron promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein]] more ... CTD PMID:17172471 iron(0) increases phosphorylation ISO RGD:620666 6480464 Iron results in increased phosphorylation of MAP2K6 protein CTD PMID:17172471 iron(2+) sulfate (anhydrous) multiple interactions ISO RGD:620666 6480464 ferrous sulfate promotes the reaction [MAP3K7 protein results in increased phosphorylation of MAP2K6 protein] more ... CTD PMID:17172471 iron(2+) sulfate (anhydrous) increases phosphorylation ISO RGD:620666 6480464 ferrous sulfate results in increased phosphorylation of MAP2K6 protein CTD PMID:17172471 L-ascorbic acid multiple interactions ISO RGD:732805 6480464 Ascorbic Acid inhibits the reaction [Fenretinide results in increased phosphorylation of MAP2K6 protein] CTD PMID:16407847 lead diacetate multiple interactions ISO RGD:732805 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA CTD PMID:12634122 lipopolysaccharide multiple interactions EXP 6480464 IRAK2 protein promotes the reaction [Lipopolysaccharides results in increased activity of MAP2K6 protein] CTD PMID:21291324 lipopolysaccharide increases activity EXP 6480464 Lipopolysaccharides results in increased activity of MAP2K6 protein CTD PMID:21291324 lycopene decreases expression ISO RGD:732805 6480464 lycopene results in decreased expression of MAP2K6 protein CTD PMID:17337101 maneb multiple interactions EXP 6480464 [Maneb co-treated with Paraquat] results in increased expression of MAP2K6 mRNA more ... CTD PMID:23963992 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of MAP2K6 mRNA] CTD PMID:23963992 mercury dibromide decreases expression ISO RGD:732805 6480464 mercuric bromide results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:732805 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 mercury dichloride decreases expression ISO RGD:732805 6480464 Mercuric Chloride results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 methotrexate affects response to substance ISO RGD:732805 6480464 MAP2K6 protein affects the susceptibility to Methotrexate CTD PMID:16217747 methotrexate decreases expression ISO RGD:732805 6480464 Methotrexate results in decreased expression of MAP2K6 mRNA CTD PMID:19100307 methylmercury chloride decreases expression ISO RGD:732805 6480464 methylmercuric chloride results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 , PMID:28001369 mevinphos increases phosphorylation ISO RGD:620666 6480464 Mevinphos results in increased phosphorylation of MAP2K6 protein CTD PMID:23157661 N-acetyl-L-cysteine multiple interactions ISO RGD:732805 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 N-acetyl-L-cysteine multiple interactions ISO RGD:620666 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP2K6 protein] CTD PMID:18703135 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:620666 6480464 CIB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP2K6 protein] CTD PMID:28939911 N-methyl-4-phenylpyridinium increases phosphorylation ISO RGD:620666 6480464 1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP2K6 protein CTD PMID:28939911 nickel dichloride affects expression ISO RGD:620666 6480464 nickel chloride affects the expression of MAP2K6 mRNA CTD PMID:22110744 nickel dichloride increases response to substance EXP 6480464 MAP2K6 protein results in increased susceptibility to nickel chloride CTD PMID:21544193 nickel dichloride multiple interactions EXP 6480464 [incomplete Freund's adjuvant co-treated with Freund's Adjuvant co-treated with nickel chloride] results in increased expression of MAP2K6 mRNA more ... CTD PMID:21544193 , PMID:23536762 nicotine increases expression ISO RGD:620666 6480464 Nicotine results in increased expression of MAP2K6 mRNA CTD PMID:20426880 Nonylphenol increases expression ISO RGD:732805 6480464 nonylphenol results in increased expression of MAP2K6 protein CTD PMID:24039973 obeticholic acid decreases expression ISO RGD:732805 6480464 obeticholic acid results in decreased expression of MAP2K6 mRNA CTD PMID:27939613 organoselenium compound multiple interactions ISO RGD:732805 6480464 [Organoselenium Compounds binds to Copper] which results in decreased expression of MAP2K6 mRNA CTD PMID:25167922 ouabain increases expression ISO RGD:732805 6480464 Ouabain results in increased expression of MAP2K6 mRNA CTD PMID:28795476 p-chloromercuribenzoic acid decreases expression ISO RGD:732805 6480464 p-Chloromercuribenzoic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:732805 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 p-menthan-3-ol decreases expression ISO RGD:732805 6480464 Menthol results in decreased expression of MAP2K6 mRNA CTD PMID:26760959 panobinostat multiple interactions ISO RGD:732805 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of MAP2K6 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:732805 6480464 Acetaminophen results in decreased expression of MAP2K6 mRNA CTD PMID:29067470 paraquat multiple interactions EXP 6480464 [Maneb co-treated with Paraquat] results in increased expression of MAP2K6 mRNA more ... CTD PMID:23963992 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of MAP2K6 mRNA CTD PMID:19270015 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of MAP2K6 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:732805 6480464 Phenylmercuric Acetate results in decreased expression of MAP2K6 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:732805 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 phlorizin increases expression EXP 6480464 Phlorhizin results in increased expression of MAP2K6 mRNA CTD PMID:22538082 piperonyl butoxide decreases expression ISO RGD:620666 6480464 Piperonyl Butoxide results in decreased expression of MAP2K6 mRNA CTD PMID:22484513 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of MAP2K6 mRNA CTD PMID:20813756 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of MAP2K6 mRNA CTD PMID:20813756 , PMID:23811191 potassium chromate multiple interactions ISO RGD:732805 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP2K6 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:732805 6480464 potassium chromate(VI) results in decreased expression of MAP2K6 mRNA CTD PMID:22079256 progesterone multiple interactions ISO RGD:732805 6480464 [Progesterone co-treated with Estradiol] results in increased expression of MAP2K6 mRNA CTD PMID:17404688 progesterone increases expression ISO RGD:732805 6480464 Progesterone results in increased expression of MAP2K6 mRNA CTD PMID:17404688 Ptaquiloside decreases expression ISO RGD:732805 6480464 ptaquiloside results in decreased expression of MAP2K6 mRNA CTD PMID:22143989 quercetin increases expression ISO RGD:732805 6480464 Quercetin results in increased expression of MAP2K6 mRNA CTD PMID:27514524 quercetin decreases expression ISO RGD:732805 6480464 Quercetin results in decreased expression of MAP2K6 mRNA CTD PMID:21632981 raloxifene multiple interactions ISO RGD:732805 6480464 MAP2K6 protein promotes the reaction [Raloxifene Hydrochloride results in increased expression of HMOX1 protein] CTD PMID:20888885 Ritodrine increases expression EXP 6480464 Ritodrine results in increased expression of MAP2K6 mRNA CTD PMID:23370008 rotenone decreases expression ISO RGD:620666 6480464 Rotenone results in decreased expression of MAP2K6 mRNA CTD PMID:28374803 Salinomycin multiple interactions ISO RGD:732805 6480464 [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA], [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein] CTD PMID:30796972 SB 203580 multiple interactions ISO RGD:620666 6480464 SB 203580 inhibits the reaction [MAP2K6 protein results in decreased expression of EP300 protein] CTD PMID:15767673 SB 431542 multiple interactions ISO RGD:732805 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane increases phosphorylation ISO RGD:732805 6480464 sevoflurane results in increased phosphorylation of MAP2K6 protein CTD PMID:18349187 silicon dioxide decreases expression ISO RGD:732805 6480464 Silicon Dioxide analog results in decreased expression of MAP2K6 mRNA, Silicon Dioxide results in decreased expression of MAP2K6 mRNA CTD PMID:22300531 , PMID:25895662 sodium arsenite multiple interactions ISO RGD:732805 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA more ... CTD PMID:12634122 , PMID:9442025 sodium arsenite increases expression ISO RGD:732805 6480464 sodium arsenite results in increased expression of MAP2K6 mRNA CTD PMID:17879257 sodium dichromate affects expression ISO RGD:620666 6480464 sodium bichromate affects the expression of MAP2K6 mRNA CTD PMID:22110744 Soman decreases expression ISO RGD:620666 6480464 Soman results in decreased expression of MAP2K6 mRNA CTD PMID:19281266 streptozocin increases expression ISO RGD:620666 6480464 Streptozocin results in increased expression of MAP2K6 mRNA CTD PMID:25905778 sulfates multiple interactions ISO RGD:732805 6480464 [Soot co-treated with Sulfates] affects the methylation of MAP2K6 promoter CTD PMID:25395096 sulforaphane decreases expression ISO RGD:732805 6480464 sulforafan results in decreased expression of MAP2K6 mRNA CTD PMID:26833863 tanespimycin multiple interactions ISO RGD:732805 6480464 [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA], [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein] CTD PMID:30796972 tert-butyl hydroperoxide increases phosphorylation ISO RGD:732805 6480464 tert-Butylhydroperoxide results in increased phosphorylation of MAP2K6 protein CTD PMID:17003459 testosterone multiple interactions ISO RGD:620666 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MAP2K6 mRNA] CTD PMID:20032058 thioacetamide decreases expression ISO RGD:620666 6480464 Thioacetamide results in decreased expression of MAP2K6 mRNA CTD PMID:23411599 trichostatin A increases expression ISO RGD:620666 6480464 trichostatin A results in increased expression of MAP2K6 mRNA CTD PMID:23558232 trichostatin A multiple interactions ISO RGD:732805 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO RGD:732805 6480464 trichostatin A results in decreased expression of MAP2K6 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A increases expression ISO RGD:732805 6480464 trichostatin A results in increased expression of MAP2K6 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:620666 6480464 trichostatin A inhibits the reaction [Cisplatin results in decreased expression of MAP2K6 mRNA] CTD PMID:23558232 trimethyltin decreases expression EXP 6480464 trimethyltin results in decreased expression of MAP2K6 mRNA CTD PMID:21435392 tris(2-butoxyethyl) phosphate affects expression ISO RGD:732805 6480464 tris(2-butoxyethyl) phosphate affects the expression of MAP2K6 mRNA CTD PMID:29024780 troglitazone decreases expression ISO RGD:732805 6480464 troglitazone results in decreased expression of MAP2K6 mRNA CTD PMID:19140230 urethane decreases expression ISO RGD:732805 6480464 Urethane results in decreased expression of MAP2K6 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:732805 6480464 Valproic Acid results in increased expression of MAP2K6 mRNA CTD PMID:24935251 , PMID:29154799 valproic acid multiple interactions ISO RGD:732805 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP2K6 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:732805 6480464 Valproic Acid results in decreased expression of MAP2K6 mRNA CTD PMID:23179753 more ... vanadium atom increases expression ISO RGD:732805 6480464 Vanadium results in increased expression of MAP2K6 mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:732805 6480464 Vanadium results in increased expression of MAP2K6 mRNA CTD PMID:19000753
Gene-Chemical Interaction Annotations
